Skip to main content
Global
Global Fin Swe Nor Den Ger Cze Svk Pol Hun Nld Bel (nl) Bel (fr) USA
Log in
  • Aidian – Your aid in diagnostics
  • Products
  • About us
  • News
  • Antimicrobial resistance
  • Aidian Academy
  • Customer stories
  • Events
  • For distributors / Log in
Contact us Search
Logo
Contact us
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
  • Respiratory tract infections
  • Products available in the USA
Point of care
  • QuikRead go system
  • QuikRead 101
Read more
QuikRead go
  • QuikRead go Plus Instrument
  • QuikRead go Instrument
  • QuikRead go easy CRP
  • QuikRead go CRP
  • QuikRead go CRP+Hb
  • QuikRead go wrCRP
  • QuikRead go wrCRP+Hb
  • QuikRead go HbA1c
  • QuikRead go Strep A
  • QuikRead go iFOBT
  • QuikRead go accessories
QuikRead go
Microbiology
  • Uricult
  • Uricult Vet
  • Cultura M
Read more
Molecular diagnostics
  • SIBA
Read more
SIBA licensing and partnering opportunities
Read more
Hygiene monitoring
  • Easicult
  • Hygicult
  • Clean Card PRO
Read more
NEW! A comprehensive guide to monitoring surface hygiene now published
Read more
RIA / Collagens
  • UniQ
Read more
  • Our history
  • Board and management
  • Sustainability
  • Culture
  • Careers
  • Employee stories
  • Partnering and licensing
  • UN Global Compact Commitment | Aidian
  • News
  • Product news
  • AMR
  • Events
  • Stories from customers
  • COVID-19
  • About C-reactive protein (CRP)
  • AMR interview
  • CRP and lower respiratory tract infections
  • Educational materials
  • QuikRead go CRP products
  • Spreading of antibiotic resistant bacteria
  • Useful links
  • Generally
  • Product information
  • Courses
  • Documents and materials
  • Frequently asked questions
  • Sleeping hygiene: monitoring cleanliness of pillows and bedding
Logo
Contact us Close
  • Products
    • Point of care
      • QuikRead go system
      • QuikRead 101
    • Microbiology
      • Uricult
      • Uricult Vet
      • Cultura M
    • Molecular diagnostics
      • SIBA
    • Hygiene monitoring
      • Easicult
      • Hygicult
      • Clean Card PRO
    • RIA / Collagens
      • UniQ
    • Respiratory tract infections
    • Products available in the USA
  • About us
    • Our history
    • Board and management
    • Sustainability
    • Culture
    • Careers
    • Employee stories
    • Partnering and licensing
    • UN Global Compact Commitment | Aidian
  • News
    • News
    • Product news
    • AMR
    • Events
    • Stories from customers
    • COVID-19
  • Antimicrobial resistance
    • About C-reactive protein (CRP)
    • AMR interview
    • CRP and lower respiratory tract infections
    • Educational materials
    • QuikRead go CRP products
    • Spreading of antibiotic resistant bacteria
    • Useful links
  • Aidian Academy
    • Generally
    • Product information
    • Courses
    • Documents and materials
    • Frequently asked questions
  • Customer stories
    • Sleeping hygiene: monitoring cleanliness of pillows and bedding
  • Events
  • For distributors / Log in
Popular products
QuikRead go Plus Instrument

QuikRead go Plus Instrument

QuikRead go HbA1c

QuikRead go HbA1c

SIBA

SIBA

Latest news
View all

May 5 is World Hand Hygiene Day

May 5, 2025 | News, Product news

Meet us at EuroMedLab 2025!

April 29, 2025 | Events

Are you prepared for tick season?

April 9, 2025 | News, Product news

  • View all
  • No results found
  • Loading...
News

May 5 is World Hand Hygiene Day

May 5, 2025 | News, Product news

Meet us at EuroMedLab 2025!

April 29, 2025 | Events

Back to all news
September 11, 2020
News,
COVID-19

Antimicrobial resistance could be the next pandemic after COVID-19

The current COVID-19 pandemic appears to have accelerated the threat of antimicrobial resistance, as many patients in the hospitals displaying COVID-19 symptoms are treated with antibiotics to reduce their chances of contracting secondary bacterial infections. This is making resistant bacteria more common. It has been estimated that up to 95% of COVID-19 inpatients are being prescribed antibiotics as part of their treatment.1

As with most colds and flus, coronavirus is a viral infection, which means treating it with antibiotics is useless and this shows need for faster testing for coronavirus and other infections, which could reduce overuse of antibiotics. United Nations’ Ad hoc Interagency Coordinating Group on Antimicrobial Resistance has warned that if action is not taken, drug-resistant diseases could cause 10 million deaths each year by 2050.

Learn more how QuikRead go C-reactive protein (CRP) can be used when assessing the severity of COVID-19.

Ref 1. Antibiotics used for treating COVID-19 patients may result in increased resistance to drugs' benefits. Accessed 11.9.2020.

Share
Facebook
Twitter
Email

Aidian Oy

Koivu-Mankkaan tie 6 B,
FI-02200 Espoo,
Finland

P.O. Box 83,
FI-02101 Espoo,
Finland

+358 10 309 3000
Company
  • About us
  • Careers
  • Contact us
  • Events
  • Product-specific inquiries
  • Sales support
  • Sales related inquiries
  • Sustainability
Products
  • Point of care
  • Microbiology
  • Molecular diagnostics
  • Hygiene monitoring
  • RIA / Collagens
  • Respiratory tract infections
Quick links
  • Aidian Academy
  • Aidian Connect
  • IFU Revision histories
Copyright © 2025 Aidian
  • Privacy Policy
  • Privacy Statements
  • Cookie Policy
  • Social Media Policy